AddLife ABSTU:1AD1 +0.13%88 Interest Coverage is 4.98 as of Mar. 2026, which is 67% below its 10-year median of 15.29. GuruFocus rates STU:1AD1 with a GF Score™ of 88/100 and a GF Value™ of €13.31. The stock has 5 warning signs investors should review. Among 466 Medical Devices & Instruments companies, AddLife AB ranks worse than 77.04% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. AddLife AB's
Operating Income
for the
three
months ended in Mar. 2026 was €21.3 Mil. AddLife AB's Interest Expense for the
three
months ended in Mar. 2026 was €-4.3 Mil.
AddLife AB's interest coverage for the quarter that ended in Mar. 2026 was 4.98.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for AddLife AB's Interest Coverage or its related term are showing as below:
STU:1AD1'
s Interest Coverage Range Over the Past 10 Years
Min: 1.58 Med: 15.29 Max: 32.44
Current: 4.84
STU:1AD1's Interest Coverage is ranked worse than 77.04% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs STU:1AD1: 4.84
AddLife AB (STU:1AD1) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
AddLife AB Interest Coverage Related Terms
AddLife AB Interest Coverage Historical Data
* Premium members only.
The historical data trend for AddLife AB's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
STU:1AD1 vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, AddLife AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AddLife AB Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where AddLife AB's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AddLife AB (STU:1AD1) has a Interest Coverage of 4.98 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on AddLife AB and its competitors. This is 67% below median its historical median of 15.29. Over the past decade, AddLife AB's Interest Coverage has ranged from 1.58 to 32.44. According to the industry distribution chart, AddLife AB ranks #359 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 77%.
Is AddLife AB's Interest Coverage too high?
AddLife AB's current Interest Coverage of 4.98 is 67% below median its 10-year median of 15.29. Over the past 10 years, this metric has ranged from a low of 1.58 to a high of 32.44. The Medical Devices & Instruments industry median Interest Coverage is 15.88. AddLife AB's value of 4.98 is 68.6% below this industry median. Based on the distribution chart, AddLife AB ranks #359 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, AddLife AB has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AddLife AB ranks #359 out of 466 companies for Interest Coverage. This places AddLife AB in the lower half of its industry. The industry median Interest Coverage is 15.88. AddLife AB's value of 4.98 is 68.6% below this benchmark. Historically, AddLife AB's own Interest Coverage has ranged from 1.58 to 32.44 over the past decade. While the company's 10-year median is 15.29 vs. the industry median of 15.88, AddLife AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AddLife AB's current Interest Coverage of 4.98 is 68.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on AddLife AB and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AddLife AB's current Interest Coverage is 4.98, which is 67% below median its own 10-year median of 15.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
AddLife AB (STU:1AD1) has a current Interest Coverage of 4.98. The stock's GF Value™ is €13.31, compared to a current price of €15.34 — trading 15.3% above its estimated fair value. The current Interest Coverage is 4.98, which is 67% below median its 10-year median of 15.29 and 68.6% below the Medical Devices & Instruments industry median of 15.88. AddLife AB's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For AddLife AB (STU:1AD1), the current Interest Coverage is 4.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AddLife AB (STU:1AD1) Overvalued in 2026?
Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued.
The current stock price of €15.34 is trading 15.3% above its estimated GF Value™ of €13.31.
Key valuation signals for STU:1AD1:
Interest Coverage: 4.98 (67% below median its 10-year median of 15.29)
GF Value™: €13.31 vs. price of €15.34 (15.3% above fair value)
Industry Position: 68.6% below the Medical Devices & Instruments median (#359 of 466)
No single metric tells the full story. See the STU:1AD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
88GF Score
Get the complete analysis for STU:1AD1
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:1AD1 has been successfully added to your 
